Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 23, 2024.
All times in Eastern Daylight Time.
-
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares DistributionNEW YORK--(BUSINESS WIRE)--On May 23, 2024, BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (Ticker: XALCX) declared a distribution of $2.00 per share of common stock, payable on June 2... more »
-
KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024ANEW YORK--(BUSINESS WIRE)--KBRA has assigned a long-term rating of AAA to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lie... more »
-
Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase ProgramHOUSTON--(BUSINESS WIRE)--Stellar Bancorp, Inc. (the “Company”) (NYSE: STEL) today announced that on May 23, 2024, its Board of Directors declared a quarterly cash dividend in the amount of $0.13 p... more »
-
Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic CancerBOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the initial interim safety and ... more »
-
MINNEAPOLIS--(BUSINESS WIRE)--NMDPSM, a global nonprofit leader in cell therapy, and the CIBMTR® (Center for International Blood and Marrow Transplant Research®), announced that interim results fro... more »
-
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced new research from the company’s diverse oncology por... more »
-
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual MeetingFLORENCE, Italy & NEW YORK--(BUSINESS WIRE)--The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-... more »
-
Dentalcorp Announces Annual General Meeting Voting ResultsTORONTO--(BUSINESS WIRE)--Dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company"), (TSX: DNTL) Canada’s largest and one of North America's fastest growing networks of dental practices, announced t... more »
-
AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid CancerNATICK, Mass.--(BUSINESS WIRE)--AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer more »
-
Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual MeetingCAMBRIDGE, Mass.--(BUSINESS WIRE)--Incendia Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), today a... more »
-
Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth StrategyWEST PALM BEACH, Fla.--(BUSINESS WIRE)--Comvest Partners, a leading middle-market private equity and credit investment firm, is pleased to announce that its direct lending platform, Comvest Credit ... more »
-
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual MeetingPRAGUE & BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--SOTIO to present Trial-in-Progress poster on the first-in-human DUET-01 Phase 1/2 study at 2024 ASCO Annual Meeting. more »
-
NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingFRANKFURT, Germany--(BUSINESS WIRE)--NeraCare, a leading developer of laboratory tests for personalized survival prediction of melanoma patients, today announced publication of an abstract describi... more »
-
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual MeetingMENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced it will present new data ... more »
-
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced new research from the company’s diverse oncology portfolio will be presented at the 2024 Americ... more »